Last updated: February 20, 2026
What is NDC 72060-0142?
NDC 72060-0142 is a brand-name drug, identified by the National Drug Code (NDC) number. This specific NDC pertains to [drug name], approved for the treatment of [indication]. It is marketed by [manufacturer].
Note: Specific drug name and manufacturer details require confirmation from official databases as the provided NDC appears to be a placeholder or not publicly listed.
Current Market Landscape
Market Size and Revenue
- Estimated global market value: $[value] billion in 2022.
- US market size: Approximately $[value] billion in sales.
- Growth rate: Compound annual growth rate (CAGR) of [X]% projected from 2023 to 2028.
Key Competitors and Alternatives
| Drug Name |
Manufacturer |
Indication |
Approval Year |
Market Share (2022) |
| [Competitor A] |
[Company X] |
[Indication] |
[Year] |
[X]% |
| [Competitor B] |
[Company Y] |
[Indication] |
[Year] |
[X]% |
| [Brand-name NDC] |
[Manufacturer] |
[Indication] |
[Year] |
[X]% |
Regulatory Status
- Approved by FDA in [Year].
- Covered by [Insurance Plans/Medicare/Medicaid] in the US.
- Available in [number] countries, subject to local approval processes.
Market Dynamics
- The [indication] market is driven by an aging population, increased diagnosis rates, and advances in drug formulations.
- Key barriers include high drug prices, patent exclusivity periods, and generic competition.
Price Trends and Projections
Historical Pricing Data
| Year |
Average Wholesale Price (AWP) |
Patient Out-of-Pocket |
Reimbursement Rate |
| 2020 |
$[value] |
$[value] |
$[value] |
| 2021 |
$[value] |
$[value] |
$[value] |
| 2022 |
$[value] |
$[value] |
$[value] |
Current Price Point
- Average retail price (ARP): $[value] per unit.
- Monthly treatment cost: $[value].
- Variations exist based on insurance status, geographical location, and pharmacy.
Price Drivers
- New formulations or delivery methods can increase price.
- Patent exclusivity maintains pricing power.
- Entry of generics or biosimilars may reduce prices over time.
Price Projection for 2023-2028
| Year |
Estimated Retail Price (per unit) |
Percentage Change |
Key Assumptions |
| 2023 |
$[value] |
+X% |
Patent protection remains |
| 2024 |
$[value] |
+X% |
Introduction of biosimilar |
| 2025 |
$[value] |
-X% |
Increased generic competition |
| 2026 |
$[value] |
+X% |
Innovation-driven price hikes |
| 2027 |
$[value] |
+X% |
Regulatory market expansion |
| 2028 |
$[value] |
+X% |
Market saturation |
Assumption notes: The price forecast assumes no significant policy changes or patent disputes and considers typical patent expiry timelines around 10-12 years post-approval.
Market Entry and Competitive Outlook
- The expected release of biosimilar or generic versions could significantly reduce prices within a 3-5 year horizon.
- Patent expiry likely occurs around [Year], providing potential for price erosion.
- Strategic manufacturing partnerships and pricing strategies could impact market share and revenue projections.
Key Takeaways
- The current US market for this drug is valued at approximately $[value] billion, with stable growth driven by aging demographics and increased treatment adoption.
- Price Points are expected to rise until patent expiry, with a decline forecasted afterwards owing to generic competition.
- Innovative formulations may sustain higher prices longer, though market entry of biosimilars and generics remains a primary downward pressure.
- Regulatory developments, including expanded indications or new delivery methods, could influence both market size and pricing dynamics.
FAQs
1. When is patent expiry expected for NDC 72060-0142?
Typically 10-12 years post-approval, projected around [Year].
2. What are the main competitors for this drug?
Key competitors include [Competitor A] and [Competitor B], with market shares of [X]% and [Y]% respectively.
3. How does the potential entry of generics affect pricing?
Pricing could decline by 20-40% within 2-3 years of generic approval, depending on market dynamics.
4. Has the drug received expanded indications?
Expansion of indications can boost revenue but depends on regulatory approval processes and clinical trial outcomes.
5. What are the key factors influencing drug prices over the next five years?
Patent status, generic entry, formulation innovations, regulatory changes, and insurance coverage policies.
References
[1] FDA Database. (2022). Approved Drug Products.
[2] IQVIA. (2022). National Prescription Audit.
[3] EvaluatePharma. (2022). World Market Overview.
[4] Centers for Medicare & Medicaid Services. (2022). Coverage Policies.
[5] Bloomberg Intelligence. (2022). Pharma Market Trends.
